US5192271A - Device and method for effecting an erection - Google Patents

Device and method for effecting an erection Download PDF

Info

Publication number
US5192271A
US5192271A US07/797,319 US79731991A US5192271A US 5192271 A US5192271 A US 5192271A US 79731991 A US79731991 A US 79731991A US 5192271 A US5192271 A US 5192271A
Authority
US
United States
Prior art keywords
ring
penis
needle guide
break
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/797,319
Inventor
Irvin M. Kalb
Robert H. Shaw
Michael J. Ram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US07/797,319 priority Critical patent/US5192271A/en
Application granted granted Critical
Publication of US5192271A publication Critical patent/US5192271A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/06Intravenous injection support

Definitions

  • the present invention relates to a device and method for delivering a stimulus to a flaccid penis to produce, enhance, or sustain an erection.
  • Impotency is generally defined as the inability to attain an erection of the penis adequate to participate in coitus or sustain an adequate erection to allow the male to attain orgasm or ejaculation.
  • Erection of the penis is caused by engorgement of the erectile tissue (the corpora cavernosa), a region of tissue along the sides and upper portion of the penis, with blood resulting in elongation, expansion, and stiffening of the penis.
  • This engorgement may be caused by an increase of blood flow to the erectile tissue, a decrease in blood flow from the erectile tissue, or a combination of both.
  • a non-pharmaceutical approach has been the delivery of electrical stimulation through an electrode implanted in the cavernous nerve or an electrode tipped probe placed in the rectum of the male.
  • Drugs and other substances which have been administered in the past include, testosterone and synthetic derivatives thereof, progesterone, yohimbine, damiana, ginseng, levadopa, hydergine, clomiphene, phosphorous, strychnine, cantharides, papaverine, hydralazine, sodium nitroprusside, pheoxybenzamine, and phentolamine.
  • the system should allow delivery of the stimulus prior to initiating the sexual encounter, and removal of the system so that it will not interfere either physically or psychologically with the performance of the male.
  • the system should be unobtrusive and non-interfering if it must be retained in position to maintain the erection.
  • the present invention is directed to a device and method that supplies these needs and eliminates the deficiencies of prior devices and systems.
  • the device of the invention comprises an open ring for temporary application to the penis which is particular designed for delivery of the desired stimulus.
  • the ring incorporates a needle guide for proper placement of a syringe delivered drug.
  • the ring includes an inner layer of a foam or microporous film which incorporates a drug composition suitable for transdermal delivery.
  • a third embodiment includes a similar inner layer of foam or film material which is capable, either by its composition or by being filled with a conductive material, of delivering an electrical stimulus supplied by an external source.
  • the needle guide extending from the ring surface is angled to assure that the drug is delivered to the desired location in the erectile tissue.
  • FIG. 1 is a front perspective view of a ring for drug delivery embodying features of the present invention.
  • FIG. 2 is a side perspective view of the ring of FIG. 1.
  • FIG. 3 is a front perspective view of a ring for transdermal delivery of drugs embodying features of the present invention.
  • FIG. 4 is a side perspective view of the ring of FIG. 3.
  • FIG. 5 is a front perspective view of a ring for delivery of an electrical stimulus embodying features of the invention.
  • FIG. 6 is a side perspective view of the ring of FIG. 5.
  • FIG. 7 is a side view of a prefilled drug delivery capsule for use in the ring of FIG. 1.
  • FIG. 8 is a perspective view of the ring of FIG. 1 mounted on the penis during delivery of drugs.
  • FIGS. 1 and 2 show a version of the ring 10 for syringe delivery of drugs according to the present invention.
  • the ring 10 has a diameter chosen to be slightly less than the diameter of a flaccid male penis so that when applied to the penis the ring 10 will grasp the penis but will not restrict blood flow in the penis or cause pain to the user.
  • the ring has both a flat inner and outer surface 14 and 16. Addition of a tissue compatible tacky or adhesive material 12 to the inner surface 14 of the ring 10 will aid in preventing the ring 10, when applied to the penis, from slipping or rotating from its desired position.
  • the ring 10 has a break 18 extending completely across the ring 10.
  • the ring 10 has a flexible portion 20 approximately 180° from the break 18 which renders the ring capable of bending. Suitable flexibility can be accomplished by forming the portion 20 with a thickness less than that of the rest of the ring, creating a living hinge in the portion 20, corrugated the portion 20 or constructing the portion 20 of a different, more flexible material.
  • the ring 10 may be formed from a flexible material that allows flexing and bending without the addition of a separated flexible portion.
  • Placement of the ring 10 is accomplished by expanding the ring diameter by pulling apart the ring halves at the break 18, this action being aided by the presence of the flexible portion 20. This spreading action is further aided by the presence of a left and right tab 22 and 24 attached to the ring, the left tab 22 being located on one side of the break 20 and the right tab 24 being located on the other side of the break 20, each tab being easily grasped between the fingers of the user of the ring 10.
  • a right or left extension tube 26 and 27 Extending from the outer surface 16 of the ring 10, preferably midway across the width of the ring, and spaced from the flexible portion are a right or left extension tube 26 and 27.
  • the tubes 26 and 27 are preferably angled from the outer surface 16 of the ring 10 so that when the ring 10 is applied to the penis the outer end 29 of the tube 26 points away from the abdomen of the user, preferably oriented in a plane perpendicular to the sides of the ring.
  • the angle of the tube is selected so that a syringe needle placed through the tube 26 or 27 penetrates only through the penile erectile tissue and does not enter the other tissue of the penis.
  • the penile erectile tissues extend along the length of the upper sides of the penis.
  • the orientation of the tubes 26 and 27 are chosen so that the tubes, when the ring is placed on the penis, point approximately in the same direction as the erectile tissue.
  • the angle of the tubes 26 and 27 to the surface of the ring 10 may be from about 10 to 75 degrees with a preferred angle being from about 15 to about 45 degrees; a more preferred angle being 25 degrees.
  • the ring 10 at the point of attachment of the extension tube 26 has a hole 28 through its surface, the hole coinciding with the internal bore 30, so that a needle placed inside the bore 30 of the tube 26 can penetrate beyond the inner surface 14 of the ring 10.
  • the ring 10 may be constructed with a single extension tube 26 on either side of the flexible portion 20 or two extension tubes 26 and 27, one on each side of the flexible portion 20.
  • FIGS. 3 and 4 shows a ring 10 of similar construction except that the extension tubes 26 or 27 are not present.
  • a coating 32 which may also have adhesive characteristics, which has the capacity to release, at a predetermined rate, an erection stimulating pharmaceutical.
  • Suitable drug delivery media includes dimethyl sulfoxide, viscolelastics such as hyaluronic acid, glycerine compounds, saline solutions and solutions of polyvinyl alcohol, hydroxyl ethyl methyl cellulose or methyl cellulose.
  • FIGS. 5 and 6 likewise show a ring 10 of similar construction to the ring 10 of FIGS. 1 and 2 wherein the adhesive 12 is replaced by an electrically conductive material 34, which may also be conductive, for delivery of an erection stimulating electrical current to the penis.
  • Suitable electrically conductive materials includes conductive media applied to the skin contacting surface of disposable EKG electrodes.
  • the electrical charge can be delivered from an external source through wires 36 and 38 connected to the electrically conductive material 34 or a electrical energy storage cell such as a battery, capacitor or other suitable source of electrical energy external to the ring or incorporated in the ring structure. While it is possible that a suitable erection can be obtained by the delivery of a single dose of energy, it may be necessary, to sustain an erection, that the electrical delivery ring be retained on the penis during coitus.
  • the ring is placed on the penis close to the abdomen with the brake 18 straddling the urethra which runs along the center of the bottom of the penis, as shown in FIG. 8. If the syringe embodiment is used the ring is placed so that the needle guide projects away from the abdomen. In its preferred form a syringe needle placed in the needle guide penetrates the outer skin of the penis and enters the erectile tissue without penetrating any of the surrounding tissue or exiting the erectile tissue. Erection stimulating drugs delivered to other than the erectile tissue is ineffective in creating an erection and may cause an extremely uncomfortable burning sensation in the penis.
  • FIG. 7 shows an example of a disposable drug delivery ampule for use with the ring 10 shown in FIGS. 1 and 2.
  • FIG. 8 shows the ampule of FIG. 7 installed in a syringe in use during delivery of a bolus of drug using the extension tube 26 located on the right side of the ring 10.
  • the syringe shown is merely representative of a drug delivery device suitable for use with the invention.
  • Various different disposable or reusable syringes known to the art or developed in the future may be utilized to inject the desired drugs into the penis.
  • the preferred drug delivery device will utilize a small diameter needle (preferably an 18 to 24 gauge needle) which can be placed in the erectile tissue with a minimum of pain or sensation to the user.
  • the ring After syringe delivery of the erection inducing drug the ring can be removed from the penis. Erection can usually be maintained for 2 to 3 hours without additional administration of the stimulant.
  • Use of the ring with needle guide embodying the invention is an extremely effective, accurate and controllable method of creating a penile erection on demand without many of the hazards and inconsistencies of the prior art techniques.
  • the ring may be constructed from any of a variety of metals or plastics and may be either reusable or disposable. Suitable materials include stiff but flexible plastic materials such as polyethylene, polypropylene, or other similar materials. Suitable dimensions for the ring are 1/2 to 2 inches in diameter, 1/4 to 1 1/2 inches in width and at least about 1/32nd inches in thickness. The preferred width is about 1 inch.
  • the rings are usually made in several different diameters to snugly fit the diameter of the flaccid penis of the user which may vary in diameter.
  • the tubes may be about 1/4 to about 2 inches in length having an inner diameter sized for easy placement of the preferred syringe needle.

Abstract

A device for delivering an erection causing stimulus to the penis comprising a ring for placement of the penis. In one variation of the device the ring includes a needle guide projecting from the surface of the ring. In a second variation the ring includes a porous drug delivery media attached to the inner surface of the ring. In a third variation the ring has an electrically conductive material attached to the inner surface of the ring.

Description

BACKGROUND
The present invention relates to a device and method for delivering a stimulus to a flaccid penis to produce, enhance, or sustain an erection.
Because of psychological or physiological reasons many older males as well as some younger men suffer from impotency. Impotency is generally defined as the inability to attain an erection of the penis adequate to participate in coitus or sustain an adequate erection to allow the male to attain orgasm or ejaculation.
Many solutions to this problem have been suggested in the past including tourniquets, straps, bands, sleeves or other supportive devices, various different implantable devices, drugs and electrical stimulation. These various different procedures or devices have met varying success. Additionally, some of these techniques can be uncomfortable, inconvenient or dangerous to use, causing irreversible injury to the user. Devices which must be worn by the male during intercourse can interfere with the sexual act and be psychologically disturbing to the male as well as be painful or distracting to either or both of the participants. The implantable devices require a surgical procedure and therefore are not suitable for all males. Drugs, if not properly administered, will not only cause an erection but can also cause undesirable systemic responses such as severe headaches, breathing problems and heart irregularities.
Erection of the penis is caused by engorgement of the erectile tissue (the corpora cavernosa), a region of tissue along the sides and upper portion of the penis, with blood resulting in elongation, expansion, and stiffening of the penis. This engorgement may be caused by an increase of blood flow to the erectile tissue, a decrease in blood flow from the erectile tissue, or a combination of both.
A non-pharmaceutical approach has been the delivery of electrical stimulation through an electrode implanted in the cavernous nerve or an electrode tipped probe placed in the rectum of the male.
In spite of their disadvantages and side effects, drugs have been used most effectively to aid in generating an erection. Drugs and other substances which have been administered in the past include, testosterone and synthetic derivatives thereof, progesterone, yohimbine, damiana, ginseng, levadopa, hydergine, clomiphene, phosphorous, strychnine, cantharides, papaverine, hydralazine, sodium nitroprusside, pheoxybenzamine, and phentolamine.
No universally acceptable modality for the relief of impotency has been endorsed by the medical community. Various stimuli, including drugs and electrical stimulation, are presently utilized to at least temporarily (for a period adequate to perform sexual intercourse) relieve this problem. In spite of the lack of agreement on a preferred treatment modality, the number of prescriptions for erection enhancing drugs, particularly drugs for injecting directly into the tissue of the penis, has been rapidly increasing. However, there is no safe, reliable system available for injecting these drugs. As a result, the users are exposing themselves to the danger of overdose, and physical injury resulting from improper placement of the needle.
Thus, there is a need for a system which will allow discrete, safe, painless and reliable delivery of the stimulus which will bring about the desired, temporary relief of impotency. Preferably, the system should allow delivery of the stimulus prior to initiating the sexual encounter, and removal of the system so that it will not interfere either physically or psychologically with the performance of the male. As a minimum, the system should be unobtrusive and non-interfering if it must be retained in position to maintain the erection.
SUMMARY
The present invention is directed to a device and method that supplies these needs and eliminates the deficiencies of prior devices and systems.
The device of the invention comprises an open ring for temporary application to the penis which is particular designed for delivery of the desired stimulus. In one embodiment, the ring incorporates a needle guide for proper placement of a syringe delivered drug. In a second embodiment the ring includes an inner layer of a foam or microporous film which incorporates a drug composition suitable for transdermal delivery. A third embodiment includes a similar inner layer of foam or film material which is capable, either by its composition or by being filled with a conductive material, of delivering an electrical stimulus supplied by an external source.
In the embodiment designed for syringe delivery of a drug, the needle guide extending from the ring surface is angled to assure that the drug is delivered to the desired location in the erectile tissue.
DRAWINGS
These and other features, aspects and advantages of the present invention will become better understood from the following description, appended claims, and accompanying drawings where:
FIG. 1 is a front perspective view of a ring for drug delivery embodying features of the present invention.
FIG. 2 is a side perspective view of the ring of FIG. 1.
FIG. 3 is a front perspective view of a ring for transdermal delivery of drugs embodying features of the present invention.
FIG. 4 is a side perspective view of the ring of FIG. 3.
FIG. 5 is a front perspective view of a ring for delivery of an electrical stimulus embodying features of the invention.
FIG. 6 is a side perspective view of the ring of FIG. 5.
FIG. 7 is a side view of a prefilled drug delivery capsule for use in the ring of FIG. 1.
FIG. 8 is a perspective view of the ring of FIG. 1 mounted on the penis during delivery of drugs.
DESCRIPTION
FIGS. 1 and 2 show a version of the ring 10 for syringe delivery of drugs according to the present invention.
The ring 10 has a diameter chosen to be slightly less than the diameter of a flaccid male penis so that when applied to the penis the ring 10 will grasp the penis but will not restrict blood flow in the penis or cause pain to the user. In a preferred form the ring has both a flat inner and outer surface 14 and 16. Addition of a tissue compatible tacky or adhesive material 12 to the inner surface 14 of the ring 10 will aid in preventing the ring 10, when applied to the penis, from slipping or rotating from its desired position.
In order to ease placement of the ring 10 onto the penis, the ring 10 has a break 18 extending completely across the ring 10. The ring 10 has a flexible portion 20 approximately 180° from the break 18 which renders the ring capable of bending. Suitable flexibility can be accomplished by forming the portion 20 with a thickness less than that of the rest of the ring, creating a living hinge in the portion 20, corrugated the portion 20 or constructing the portion 20 of a different, more flexible material. In the alternative, the ring 10 may be formed from a flexible material that allows flexing and bending without the addition of a separated flexible portion.
Placement of the ring 10 is accomplished by expanding the ring diameter by pulling apart the ring halves at the break 18, this action being aided by the presence of the flexible portion 20. This spreading action is further aided by the presence of a left and right tab 22 and 24 attached to the ring, the left tab 22 being located on one side of the break 20 and the right tab 24 being located on the other side of the break 20, each tab being easily grasped between the fingers of the user of the ring 10.
Extending from the outer surface 16 of the ring 10, preferably midway across the width of the ring, and spaced from the flexible portion are a right or left extension tube 26 and 27. The tubes 26 and 27 are preferably angled from the outer surface 16 of the ring 10 so that when the ring 10 is applied to the penis the outer end 29 of the tube 26 points away from the abdomen of the user, preferably oriented in a plane perpendicular to the sides of the ring. The angle of the tube is selected so that a syringe needle placed through the tube 26 or 27 penetrates only through the penile erectile tissue and does not enter the other tissue of the penis. The penile erectile tissues extend along the length of the upper sides of the penis. The orientation of the tubes 26 and 27 are chosen so that the tubes, when the ring is placed on the penis, point approximately in the same direction as the erectile tissue. The angle of the tubes 26 and 27 to the surface of the ring 10 may be from about 10 to 75 degrees with a preferred angle being from about 15 to about 45 degrees; a more preferred angle being 25 degrees. The ring 10 at the point of attachment of the extension tube 26 has a hole 28 through its surface, the hole coinciding with the internal bore 30, so that a needle placed inside the bore 30 of the tube 26 can penetrate beyond the inner surface 14 of the ring 10. The ring 10 may be constructed with a single extension tube 26 on either side of the flexible portion 20 or two extension tubes 26 and 27, one on each side of the flexible portion 20.
FIGS. 3 and 4 shows a ring 10 of similar construction except that the extension tubes 26 or 27 are not present. Added to the inner surface 14, in place of the adhesive 12, is a coating 32, which may also have adhesive characteristics, which has the capacity to release, at a predetermined rate, an erection stimulating pharmaceutical. Suitable drug delivery media includes dimethyl sulfoxide, viscolelastics such as hyaluronic acid, glycerine compounds, saline solutions and solutions of polyvinyl alcohol, hydroxyl ethyl methyl cellulose or methyl cellulose.
FIGS. 5 and 6 likewise show a ring 10 of similar construction to the ring 10 of FIGS. 1 and 2 wherein the adhesive 12 is replaced by an electrically conductive material 34, which may also be conductive, for delivery of an erection stimulating electrical current to the penis. Suitable electrically conductive materials includes conductive media applied to the skin contacting surface of disposable EKG electrodes. The electrical charge can be delivered from an external source through wires 36 and 38 connected to the electrically conductive material 34 or a electrical energy storage cell such as a battery, capacitor or other suitable source of electrical energy external to the ring or incorporated in the ring structure. While it is possible that a suitable erection can be obtained by the delivery of a single dose of energy, it may be necessary, to sustain an erection, that the electrical delivery ring be retained on the penis during coitus.
To deliver the erectile stimulus the ring is placed on the penis close to the abdomen with the brake 18 straddling the urethra which runs along the center of the bottom of the penis, as shown in FIG. 8. If the syringe embodiment is used the ring is placed so that the needle guide projects away from the abdomen. In its preferred form a syringe needle placed in the needle guide penetrates the outer skin of the penis and enters the erectile tissue without penetrating any of the surrounding tissue or exiting the erectile tissue. Erection stimulating drugs delivered to other than the erectile tissue is ineffective in creating an erection and may cause an extremely uncomfortable burning sensation in the penis.
FIG. 7 shows an example of a disposable drug delivery ampule for use with the ring 10 shown in FIGS. 1 and 2. FIG. 8 shows the ampule of FIG. 7 installed in a syringe in use during delivery of a bolus of drug using the extension tube 26 located on the right side of the ring 10. However, the syringe shown is merely representative of a drug delivery device suitable for use with the invention. Various different disposable or reusable syringes known to the art or developed in the future may be utilized to inject the desired drugs into the penis. The preferred drug delivery device will utilize a small diameter needle (preferably an 18 to 24 gauge needle) which can be placed in the erectile tissue with a minimum of pain or sensation to the user. After syringe delivery of the erection inducing drug the ring can be removed from the penis. Erection can usually be maintained for 2 to 3 hours without additional administration of the stimulant. Use of the ring with needle guide embodying the invention is an extremely effective, accurate and controllable method of creating a penile erection on demand without many of the hazards and inconsistencies of the prior art techniques.
The ring may be constructed from any of a variety of metals or plastics and may be either reusable or disposable. Suitable materials include stiff but flexible plastic materials such as polyethylene, polypropylene, or other similar materials. Suitable dimensions for the ring are 1/2 to 2 inches in diameter, 1/4 to 1 1/2 inches in width and at least about 1/32nd inches in thickness. The preferred width is about 1 inch. The rings are usually made in several different diameters to snugly fit the diameter of the flaccid penis of the user which may vary in diameter. The tubes may be about 1/4 to about 2 inches in length having an inner diameter sized for easy placement of the preferred syringe needle.
Although the present invention has been described in considerable detail with reference to certain preferred versions and uses thereof, other versions and uses are possible. Therefore, the spirit and scope of the appended claims should not be limited to the description of the preferred versions contained herein.

Claims (16)

What is claimed is:
1. A device for delivery of a stimulus to the penis to treat impotence comprising:
a ring sized to partially but substantially encircle and contact, along the ring's entire inner surface, the penis of a human male,
the ring having a break and a flexible portion located between said first and second ends,
said ring having a uniform thickness with said flexible potion being of a reduced area of thickness therein and first and second ends spaced from each other on opposite sides of the break,
the ring being flexible so that the circumference of the ring can be manually increased by bending or by expansion of the penis,
the ring adapted for delivery of a stimulus to cause erection of the penis after placement of the ring thereon.
2. The device of claim 1 further having first and second placement means located between the flexible portion and the first and second ends.
3. The device of claim 2 wherein the first and second placement means are tabs sized for grasping between the users fingers, the tabs extending from the outer surface of the ring.
4. The device of claim 1 wherein the inner surface of the ring is at least partially coated with a skin compatible adhesive.
5. The device of claim 1 wherein the ring has at least one hole formed through its thickness and a needle guide placed over each hole, said needle guide projecting from the outer surface of the ring at an angle to the surface.
6. The device of claim 5 wherein the needle guide projects from the ring surface at an angle of about 10 degrees to about 75 degrees, said needle guide projecting toward the edge of the ring.
7. The device of claim 6 wherein the needle guide projects at an angle of about 20 to 45 degrees from the ring surface along a plane perpendicular to the edges of the ring.
8. The device of claim 5 wherein the needle guide is a tubular extension chosen to receive a small diameter hypodermic needle.
9. The device of claim 1 wherein the inner surface of the ring is coated with a material capable of dispensing a drug deliverable transcutaneously.
10. The device of claim 1 wherein the inner surface of the ring is coated with an electrically conductive material.
11. A device to aid in the delivery of an erection inducing drug to the penis comprising:
a flexible ring sized to partially encircle a flaccid penis,
the ring having a break therein to aid in properly placing the ring on the flaccid penis and at least one needle guide extending from its surface, said needle guide located above the penile erectile tissue and the break straddling the urethra when properly placed on the penis, the needle guide being angled and oriented so that a syringe needle placed through the needle guide penetrates through the covering skin and into the erectile tissue without penetrating other surrounding tissue.
12. A syringe placement guide for delivery of an erection inducing drug to the penis comprising:
a flexible ring having a flat outer surface and a flat inner surface bounded by two edges and a break extending across the width of the ring and through the edges,
a needle guide projecting at an angle to the outer surface of the the needle guide projecting at an angle to the outer surface of the ring and extending over one of the edges of the outer surface
the needle guide being located over the penile erectile tissue and the break straddling the urethra when properly placed on the penis.
13. The syringe placement device of claim 12 further having grasping means extending from the ring to aid in placing the ring on a flaccid penis.
14. The syringe placement device of claim 12 further having an adhesive material coating the inner surface of the ring.
15. The syringe placement device of claim 12 wherein the ring has a width of about 1/4 to 1 1/2 inches, a diameter of about 1/2 to 2 inches and a thickness greater than about 1/32 of an inch.
16. The syringe placement device of claim 12 wherein the needle guide projects from the ring surface at an angle of about 15 to 45 degrees.
US07/797,319 1991-11-25 1991-11-25 Device and method for effecting an erection Expired - Fee Related US5192271A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/797,319 US5192271A (en) 1991-11-25 1991-11-25 Device and method for effecting an erection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/797,319 US5192271A (en) 1991-11-25 1991-11-25 Device and method for effecting an erection

Publications (1)

Publication Number Publication Date
US5192271A true US5192271A (en) 1993-03-09

Family

ID=25170503

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/797,319 Expired - Fee Related US5192271A (en) 1991-11-25 1991-11-25 Device and method for effecting an erection

Country Status (1)

Country Link
US (1) US5192271A (en)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415647A (en) * 1994-09-15 1995-05-16 Pisarik; Paul Flexible, multi-grooved vascular immobilizer
EP0755689A1 (en) * 1995-07-25 1997-01-29 JENAPHARM GmbH Treatment of erectile dysfunction
US5752933A (en) * 1996-01-29 1998-05-19 Morrison; Malcolm S. F. G. Prostaglandin applicator
US5899875A (en) * 1994-11-16 1999-05-04 Laboratoires D'hygiene Et De Dietetique (L.H.D.) Device for percutaneous administration of medicaments for treating male impotence
US5984890A (en) * 1996-09-27 1999-11-16 American Home Products Corporation Medical device for the placement of solid materials
US6306080B1 (en) 1999-09-22 2001-10-23 Soma Blue, Inc. Disposable penile constriction device having preformed tear configuration and associated methods
WO2002051493A1 (en) * 2000-12-21 2002-07-04 Hendricksen Mark W Lubrication applicator system
US6520906B2 (en) * 2000-01-07 2003-02-18 Senji Yanagi Coitus assistance device for males
US20040152948A1 (en) * 2003-02-04 2004-08-05 Kim Ee Do Auxiliary ring for genitals
US20080234536A1 (en) * 2007-03-21 2008-09-25 Yossi Gross Implantable peristaltic pump to treat erectile dysfunction
US20090112054A1 (en) * 2007-10-29 2009-04-30 Kevin Lindberg Device to lubricate a penis or medical apparatus
US20090198308A1 (en) * 2008-01-31 2009-08-06 Enopace Biomedical Ltd. Intra-aortic electrical counterpulsation
US20090198097A1 (en) * 2008-01-31 2009-08-06 Ed Tech Medical Ltd. Peristaltic pump for treatment of erectile dysfunction
US7578296B2 (en) 2006-12-05 2009-08-25 A.L. Enterprises, Inc Male chastity apparatus, method, and system
US20100016759A1 (en) * 2008-05-05 2010-01-21 Pierre Lavoisier Device and method for measuring and treating the rigidity and erection of a penis and arterial-venous flows
US20100024830A1 (en) * 2008-07-30 2010-02-04 Ethicon, Inc. Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US20100132719A1 (en) * 2008-12-01 2010-06-03 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US20100200004A1 (en) * 2009-02-12 2010-08-12 Miller A Frank Male Chastity Apparatus, System, and Method
US20110009692A1 (en) * 2007-12-26 2011-01-13 Yossi Gross Nitric oxide generation to treat female sexual dysfunction
US20110100376A1 (en) * 2009-10-29 2011-05-05 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US20110100377A1 (en) * 2009-10-29 2011-05-05 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US20110137370A1 (en) * 2008-01-31 2011-06-09 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US20130074849A1 (en) * 2011-09-28 2013-03-28 Robert Rousseau Modular Tissue Securement Systems
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US8649863B2 (en) 2010-12-20 2014-02-11 Rainbow Medical Ltd. Pacemaker with no production
US20140073851A1 (en) * 2011-07-11 2014-03-13 Bruce Gioia Male anatomical enhancement garment
US8813754B2 (en) 2009-02-17 2014-08-26 Ethicon, Inc. Magnetic implants and methods for treating an oropharyngeal condition
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
US8862243B2 (en) 2005-07-25 2014-10-14 Rainbow Medical Ltd. Electrical stimulation of blood vessels
US8915252B2 (en) 2008-12-01 2014-12-23 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US20150032195A1 (en) * 2013-07-24 2015-01-29 GiMer Medical Co., Ltd. Desensitizing device
US20150065792A1 (en) * 2012-08-31 2015-03-05 Anthony H. Levine Hand-operated male masturbation device
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
WO2015077151A1 (en) * 2013-11-20 2015-05-28 Wake Forest University Health Sciences Needle guides suitable for penile injections and related kits
US9144511B2 (en) 2008-08-14 2015-09-29 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
USD741539S1 (en) * 2014-02-28 2015-10-20 Leeo, Inc. Nightlight and air sensor
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
US9526637B2 (en) 2011-09-09 2016-12-27 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
EA025439B1 (en) * 2008-09-09 2016-12-30 Аурис Медикал Лимитед Stimulation apparatus
US9778235B2 (en) 2013-07-17 2017-10-03 Leeo, Inc. Selective electrical coupling based on environmental conditions
US9801013B2 (en) 2015-11-06 2017-10-24 Leeo, Inc. Electronic-device association based on location duration
US9865016B2 (en) 2014-09-08 2018-01-09 Leeo, Inc. Constrained environmental monitoring based on data privileges
US9974683B2 (en) 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US10026304B2 (en) 2014-10-20 2018-07-17 Leeo, Inc. Calibrating an environmental monitoring device
US10335594B2 (en) 2013-07-24 2019-07-02 GiMer Medical Co., Ltd. Desensitizing device
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
US10483784B2 (en) 2015-06-01 2019-11-19 Lovely, Inc. Wearable, activity-tracking sex toy, and a method for its use
US10779965B2 (en) 2013-11-06 2020-09-22 Enopace Biomedical Ltd. Posts with compliant junctions
US20220218914A1 (en) * 2013-08-29 2022-07-14 Sanofi Safety Device for a Medicament Container
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US853410A (en) * 1907-01-21 1907-05-14 Ernest D Huebner Surgical appliance.
US3167072A (en) * 1962-10-11 1965-01-26 Stone Hester Ellen Intravenous needle and flow tube stabilizing means
US3794020A (en) * 1972-06-16 1974-02-26 R Bagby Anatomical device
US3957048A (en) * 1974-10-03 1976-05-18 Jacobs Herbert V Intravenous device
US4127118A (en) * 1977-03-16 1978-11-28 Alvaro Latorre Method of effecting and enhancing an erection
US4150669A (en) * 1977-03-16 1979-04-24 Alvaro Latorre Apparatus for effecting and enhancing an erection
US4314568A (en) * 1980-01-11 1982-02-09 Baxter Travenol Laboratories, Inc. Vascular stabilizer
US4844061A (en) * 1987-10-29 1989-07-04 Ergomed, Inc. Medical tube holder
US5027800A (en) * 1989-09-22 1991-07-02 Rowland Harold L Man's erection truss

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US853410A (en) * 1907-01-21 1907-05-14 Ernest D Huebner Surgical appliance.
US3167072A (en) * 1962-10-11 1965-01-26 Stone Hester Ellen Intravenous needle and flow tube stabilizing means
US3794020A (en) * 1972-06-16 1974-02-26 R Bagby Anatomical device
US3957048A (en) * 1974-10-03 1976-05-18 Jacobs Herbert V Intravenous device
US4127118A (en) * 1977-03-16 1978-11-28 Alvaro Latorre Method of effecting and enhancing an erection
US4150669A (en) * 1977-03-16 1979-04-24 Alvaro Latorre Apparatus for effecting and enhancing an erection
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4314568A (en) * 1980-01-11 1982-02-09 Baxter Travenol Laboratories, Inc. Vascular stabilizer
US4844061A (en) * 1987-10-29 1989-07-04 Ergomed, Inc. Medical tube holder
US5027800A (en) * 1989-09-22 1991-07-02 Rowland Harold L Man's erection truss

Cited By (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415647A (en) * 1994-09-15 1995-05-16 Pisarik; Paul Flexible, multi-grooved vascular immobilizer
US5899875A (en) * 1994-11-16 1999-05-04 Laboratoires D'hygiene Et De Dietetique (L.H.D.) Device for percutaneous administration of medicaments for treating male impotence
EP0755689A1 (en) * 1995-07-25 1997-01-29 JENAPHARM GmbH Treatment of erectile dysfunction
US5752933A (en) * 1996-01-29 1998-05-19 Morrison; Malcolm S. F. G. Prostaglandin applicator
US5984890A (en) * 1996-09-27 1999-11-16 American Home Products Corporation Medical device for the placement of solid materials
US6306080B1 (en) 1999-09-22 2001-10-23 Soma Blue, Inc. Disposable penile constriction device having preformed tear configuration and associated methods
US6520906B2 (en) * 2000-01-07 2003-02-18 Senji Yanagi Coitus assistance device for males
WO2002051493A1 (en) * 2000-12-21 2002-07-04 Hendricksen Mark W Lubrication applicator system
US20040152948A1 (en) * 2003-02-04 2004-08-05 Kim Ee Do Auxiliary ring for genitals
US8862243B2 (en) 2005-07-25 2014-10-14 Rainbow Medical Ltd. Electrical stimulation of blood vessels
US11197992B2 (en) 2005-07-25 2021-12-14 Enopace Biomedical Ltd. Electrical stimulation of blood vessels
US20100147316A1 (en) * 2006-12-05 2010-06-17 Miller A Frank Male chastity apparatus, method, and system
US8007431B2 (en) 2006-12-05 2011-08-30 A. L. Enterprises, Inc. Male chastity apparatus, method, and system
US7578296B2 (en) 2006-12-05 2009-08-25 A.L. Enterprises, Inc Male chastity apparatus, method, and system
US20080234536A1 (en) * 2007-03-21 2008-09-25 Yossi Gross Implantable peristaltic pump to treat erectile dysfunction
US8152711B2 (en) 2007-03-21 2012-04-10 Yossi Gross Implantable peristaltic pump to treat erectile dysfunction
US20090112054A1 (en) * 2007-10-29 2009-04-30 Kevin Lindberg Device to lubricate a penis or medical apparatus
US7963908B2 (en) * 2007-10-29 2011-06-21 Kevin Lindberg Device to lubricate a penis or medical apparatus
US20110009692A1 (en) * 2007-12-26 2011-01-13 Yossi Gross Nitric oxide generation to treat female sexual dysfunction
US20090198097A1 (en) * 2008-01-31 2009-08-06 Ed Tech Medical Ltd. Peristaltic pump for treatment of erectile dysfunction
US9005106B2 (en) 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8626299B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US20110137370A1 (en) * 2008-01-31 2011-06-09 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US7818062B2 (en) * 2008-01-31 2010-10-19 Ed Tech Medical Ltd. Peristaltic pump for treatment of erectile dysfunction
US20090198308A1 (en) * 2008-01-31 2009-08-06 Enopace Biomedical Ltd. Intra-aortic electrical counterpulsation
US20100016759A1 (en) * 2008-05-05 2010-01-21 Pierre Lavoisier Device and method for measuring and treating the rigidity and erection of a penis and arterial-venous flows
US9180284B2 (en) 2008-05-05 2015-11-10 Pierre Lavoisier Device and method for measuring and treating the rigidity and erection of a penis and arterial-venous flows
US20100024830A1 (en) * 2008-07-30 2010-02-04 Ethicon, Inc. Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US8678008B2 (en) 2008-07-30 2014-03-25 Ethicon, Inc Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea
US9144511B2 (en) 2008-08-14 2015-09-29 Ethicon, Inc. Methods and devices for treatment of obstructive sleep apnea
EA025439B1 (en) * 2008-09-09 2016-12-30 Аурис Медикал Лимитед Stimulation apparatus
US20100132719A1 (en) * 2008-12-01 2010-06-03 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8783258B2 (en) 2008-12-01 2014-07-22 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US8915252B2 (en) 2008-12-01 2014-12-23 Ethicon, Inc. Implant systems and methods for treating obstructive sleep apnea
US20100200004A1 (en) * 2009-02-12 2010-08-12 Miller A Frank Male Chastity Apparatus, System, and Method
US8505543B2 (en) 2009-02-12 2013-08-13 A.L. Enterprises, Inc. Male chastity apparatus, system, and method
US8813754B2 (en) 2009-02-17 2014-08-26 Ethicon, Inc. Magnetic implants and methods for treating an oropharyngeal condition
US20110100377A1 (en) * 2009-10-29 2011-05-05 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9877862B2 (en) 2009-10-29 2018-01-30 Ethicon, Inc. Tongue suspension system with hyoid-extender for treating obstructive sleep apnea
US9326886B2 (en) 2009-10-29 2016-05-03 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US20110100376A1 (en) * 2009-10-29 2011-05-05 Ethicon, Inc. Fluid filled implants for treating obstructive sleep apnea
US9974683B2 (en) 2009-10-30 2018-05-22 Ethicon, Inc. Flexible implants having internal volume shifting capabilities for treating obstructive sleep apnea
US9649487B2 (en) 2010-08-05 2017-05-16 Enopace Biomedical Ltd. Enhancing perfusion by contraction
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
US8649863B2 (en) 2010-12-20 2014-02-11 Rainbow Medical Ltd. Pacemaker with no production
US20140073851A1 (en) * 2011-07-11 2014-03-13 Bruce Gioia Male anatomical enhancement garment
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
US10828181B2 (en) 2011-09-09 2020-11-10 Enopace Biomedical Ltd. Annular antenna
US9526637B2 (en) 2011-09-09 2016-12-27 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US20130074849A1 (en) * 2011-09-28 2013-03-28 Robert Rousseau Modular Tissue Securement Systems
US9592046B2 (en) 2011-09-28 2017-03-14 Ethicon, Inc. Modular tissue securement systems
US8905033B2 (en) * 2011-09-28 2014-12-09 Ethicon, Inc. Modular tissue securement systems
US9161855B2 (en) 2011-10-24 2015-10-20 Ethicon, Inc. Tissue supporting device and method
US8973582B2 (en) 2011-11-30 2015-03-10 Ethicon, Inc. Tongue suspension device and method
US10470760B2 (en) 2011-12-08 2019-11-12 Ethicon, Inc. Modified tissue securement fibers
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
US9173766B2 (en) 2012-06-01 2015-11-03 Ethicon, Inc. Systems and methods to treat upper pharyngeal airway of obstructive sleep apnea patients
US20150065792A1 (en) * 2012-08-31 2015-03-05 Anthony H. Levine Hand-operated male masturbation device
US9778235B2 (en) 2013-07-17 2017-10-03 Leeo, Inc. Selective electrical coupling based on environmental conditions
US20150032195A1 (en) * 2013-07-24 2015-01-29 GiMer Medical Co., Ltd. Desensitizing device
US10335594B2 (en) 2013-07-24 2019-07-02 GiMer Medical Co., Ltd. Desensitizing device
US9370652B2 (en) * 2013-07-24 2016-06-21 Gimer Medical Co. Ltd. Desensitizing device
US10398896B2 (en) 2013-07-24 2019-09-03 GiMer Medical Co., Ltd. Desensitizing device
US20220218914A1 (en) * 2013-08-29 2022-07-14 Sanofi Safety Device for a Medicament Container
US10779965B2 (en) 2013-11-06 2020-09-22 Enopace Biomedical Ltd. Posts with compliant junctions
US11432949B2 (en) 2013-11-06 2022-09-06 Enopace Biomedical Ltd. Antenna posts
WO2015077151A1 (en) * 2013-11-20 2015-05-28 Wake Forest University Health Sciences Needle guides suitable for penile injections and related kits
US9861764B2 (en) 2013-11-20 2018-01-09 Wake Forest University Health Sciences Needle guides suitable for penile injections and related kits
USD741539S1 (en) * 2014-02-28 2015-10-20 Leeo, Inc. Nightlight and air sensor
US10043211B2 (en) 2014-09-08 2018-08-07 Leeo, Inc. Identifying fault conditions in combinations of components
US9865016B2 (en) 2014-09-08 2018-01-09 Leeo, Inc. Constrained environmental monitoring based on data privileges
US10078865B2 (en) 2014-09-08 2018-09-18 Leeo, Inc. Sensor-data sub-contracting during environmental monitoring
US10304123B2 (en) 2014-09-08 2019-05-28 Leeo, Inc. Environmental monitoring device with event-driven service
US10102566B2 (en) 2014-09-08 2018-10-16 Leeo, Icnc. Alert-driven dynamic sensor-data sub-contracting
US10026304B2 (en) 2014-10-20 2018-07-17 Leeo, Inc. Calibrating an environmental monitoring device
US10483784B2 (en) 2015-06-01 2019-11-19 Lovely, Inc. Wearable, activity-tracking sex toy, and a method for its use
US9801013B2 (en) 2015-11-06 2017-10-24 Leeo, Inc. Electronic-device association based on location duration
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Similar Documents

Publication Publication Date Title
US5192271A (en) Device and method for effecting an erection
US5741511A (en) Transdermal drug delivery device for treating erectile dysfunction
EP0526566B1 (en) Treatment of erectile dysfunction
US4801587A (en) Impotence ointment
US6214032B1 (en) System for implanting a microstimulator
US20220142953A1 (en) Lidocaine patch and methods of use thereof
US11406806B2 (en) Atraumatic trocar apparatus, system and kit
Biering-Sørensen et al. Penile erection in men with spinal cord or cauda equina lesions
US6251067B1 (en) Male erectile prosthesis
JP7314182B2 (en) Methods and instruments for rectal anesthesia
US6309344B1 (en) Male erection enhancer and sustainer
US10856907B2 (en) Atraumatic trocar medication delivery method
JPH02500718A (en) injection device
EP3501460B1 (en) Condom for patient with erectile dysfunction
KR200468397Y1 (en) Device for Extending Sexual Organs
EP0198914A1 (en) Apparatus for controlling permeation of a compound through a membrane
CN220142413U (en) Anorectal drug delivery device
RU2055605C1 (en) Method of curing neiroreceptor form of impotence
RU14352U1 (en) CATHETER FOR RETROBULBAR INFUSIONS
Hudson-allez The interface between psychogenic and organic difficulties in men with erectile dysfunction
WO2024080940A1 (en) Fixed diabetes insulin arrangement
RU2099017C1 (en) Method for stimulating female erogenous zones during coitus
Creasey Lecture 6 Restoration of male sexual function following spinal cord injury.
WO2019165131A1 (en) Atraumatic subcutaneous medication delivery
WO1997041920A1 (en) Iontophoretic delivery of a therapeutic agent to treat erectile dysfunction

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Expired due to failure to pay maintenance fee

Effective date: 20010309

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362